RBCL OTC
RBC Life Sciences, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +75.0%
1Y: +600.0%
3Y: +40.0%
5Y: -99.4%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$156K
+103.7% ▲
5Y CAGR: +4.4%
Capital Expenditures
$149K
+17.3% ▲
5Y CAGR: -15.7%
Free Cash Flow
$7K
+100.2% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$21K
+104.4% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$361K | -$500K | -$603K | -$742K | -$756K |
| Depreciation & Amort. | $585K | $588K | $580K | $502K | $415K |
| Stock-Based Comp. | $38K | $21K | $2K | $0 | $0 |
| Change in Working Capital | $518K | $418K | -$462K | -$2M | $415K |
| Other Non-Cash Items | -$443K | $3K | $0 | -$2M | $0 |
| Operating Cash Flow | $445K | $294K | -$608K | -$4M | $156K |
| — Investing Activities — | |||||
| Capital Expenditures | -$805K | -$267K | -$1M | -$180K | -$149K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $625K | $0 | $0 | $5M | $0 |
| Investing Cash Flow | -$180K | -$267K | -$1M | $5M | -$149K |
| — Financing Activities — | |||||
| Net Debt Issuance | -$182K | -$197K | -$212K | -$1M | $0 |
| Stock Repurchased | $0 | -$18K | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $0 | $0 | $894 | $0 |
| Financing Cash Flow | -$182K | -$215K | -$212K | -$1M | $0 |
| Net Change in Cash | $38K | -$150K | -$2M | -$472K | $21K |
| Cash End of Period | $4M | $4M | $2M | $1M | $1M |
| Free Cash Flow | -$360K | $27K | -$2M | -$4M | $7K |